Extracorporeal Membrane Oxygenation Support in a Situation of Diagnostic Dilemma

Randolph, 2009, Management of acute lung injury and acute respiratory distress syndrome in children, Crit Care Med, 37, 2454 ELSO general guidelines April 2009. Gaspar, 2002, X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective, Br J Haematol, 119, 585, 10.1046/j.1365-2141.2002.03851.x Coffey, 1998, Bentley DRHost response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene, Nat Genet, 20, 129, 10.1038/2424 Sumegi, 2000, Correlation of mutations of the SH2D1A gene and Epstein–Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease, Blood, 96, 3118 Arico, 2001, Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene, Blood, 97, 1131, 10.1182/blood.V97.4.1131 Milone, 2005, Treatment of primary Epstein–Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy, Blood, 105, 994, 10.1182/blood-2004-07-2965 Zabrocki, 2011, Extracorporeal membrane oxygenation for pediatric respiratory failure: survival and predictors of mortality, Crit Care Med, 39, 364, 10.1097/CCM.0b013e3181fb7b35 2004, ECMO in children with malignancy